top of page
EPIDIOLEX
Project Date: 2018 - 2019
The first and only FDA-approved prescription cannabidiol (CBD) to treat seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome, or tuberous sclerosis complex (TSC) in patients 1 year of age or older.
Client
Greenwich Biosciences
NY Creative Lead
Type of Work
Campaign Refresh
Branding
PH Creative Lead
Revitalize and elevate the EPIDIOLEX narrative with captivating visuals, transforming and unifying all campaign materials to create a seamless and compelling brand experience.
Task: Conceptualize, design and strategize
bottom of page